Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.880
+0.010 (0.53%)
At close: Sep 2, 2025, 4:00 PM
1.900
+0.020 (1.06%)
After-hours: Sep 2, 2025, 7:04 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $175.07 million as of September 2, 2025. Its market cap has increased by 1.97% in one year.
Market Cap
175.07M
Enterprise Value
16.97M
1-Year Change
1.97%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $175.07M, a decrease of -80.30%. That is a compound annual growth rate of -32.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 174.14M | 20.95% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |